New studies into retatrutide, a dual activator for GLP-1 and GIP receptors, are revealing encouraging results in addressing weight gain and related 2 diabetes. Preclinical data suggest a novel mechanism contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/